|
1
|
Blanco-Prieto S, Barcia-Castro L, Páez de
la Cadena M, Rodríguez-Berrocal FJ, Vázquez-Iglesias L, Botana-Rial
MI, Fernández-Villar A and De Chiara L: Relevance of matrix
metalloproteases in non-small cell lung cancer diagnosis. BMC
Cancer. 17:8232017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuan Y, Wu J, Li B, Niu J, Tan H and Qiu
S: Regulation of signaling pathways involved in the
anti-proliferative and apoptosis-inducing effects of M22 against
non-small cell lung adenocarcinoma A549 cells. Sci Rep. 8:9922018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen J, Wang B, Zhang T, Zhu N, Wang Z,
Jin J, He Y and Hu M: Suppression of non-small cell lung cancer
growth and metastasis by a novel small molecular activator of RECK.
Cell Physiol Biochem. 45:1807–1817. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li X, Han J, Zhu H, Peng L and Chen Z:
MiR181b5p mediates TGFbeta1-induced epithelial-to-mesenchymal
transition in non-small cell lung cancer stem-like cells derived
from lung adenocarcinoma A549 cells. Int J Oncol. 51:158–168. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Denisenko TV, Budkevich IN and Zhivotovsky
B: Cell death-based treatment of lung adenocarcinoma. Cell Death
Dis. 9:1172018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y and Zhou S: MicroRNA-29a inhibits
mesenchymal stem cell viability and proliferation by targeting
Roundabout 1. Mol Med Rep. 12:6178–6184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou S, Ye W, Zhang Y, Yu D, Shao Q, Liang
J and Zhang M: MiR-144 reverses chemoresistance of hepatocellular
carcinoma cell lines by targeting Nrf2-dependent antioxidant
pathway. Am J Transl Res. 8:2992–3002. 2016.PubMed/NCBI
|
|
8
|
Gamazon ER, Trendowski MR, Wen Y, Wing C,
Delaney SM, Huh W, Wong S, Cox NJ and Dolan ME: Gene and microRNA
perturbations of cellular response to pemetrexed implicate
biological networks and enable imputation of response in lung
adenocarcinoma. Sci Rep. 8:7332018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao F, Ge YZ, Zhou LH, Xu LW, Xu Z, Ping
WW, Wang M, Zhou CC, Wu R and Jia RP: Identification of hub miRNA
biomarkers for bladder cancer by weighted gene coexpression network
analysis. Onco Targets Ther. 10:5551–5559. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cochetti G, Poli G, Guelfi G, Boni A,
Egidi MG and Mearini E: Different levels of serum microRNAs in
prostate cancer and benign prostatic hyperplasia: Evaluation of
potential diagnostic and prognostic role. Onco Targets Ther.
9:7545–7553. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang L, Wei DM, Li JJ, Luo DZ, Chen G,
Dang YW and Cai XY: Prognostic microRNAs and their potential
molecular mechanism in pancreatic cancer: A study based on The
Cancer Genome Atlas and bioinformatics investigation. Mol Med Rep.
17:939–951. 2018.PubMed/NCBI
|
|
12
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mitra R, Lin CC, Eischen CM, Bandyopadhyay
S and Zhao Z: Concordant dysregulation of miR-5p and miR-3p arms of
the same precursor microRNA may be a mechanism in inducing cell
proliferation and tumorigenesis: A lung cancer study. RNA.
21:1055–1065. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Okamura K, Phillips MD, Tyler DM, Duan H,
Chou YT and Lai EC: The regulatory activity of microRNA* species
has substantial influence on microRNA and 3′UTR evolution. Nat
Struct Mol Biol. 15:354–363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo L, Yu J, Yu H, Zhao Y, Chen S, Xu C
and Chen F: Evolutionary and expression analysis of miR-#-5p and
miR-#-3p at the miRNAs/isomiRs levels. BioMed Res Int.
2015:1683582015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and 5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y,
Li C, Chong M, Ibrahim T, Mercatali L, et al: MiR-126 and miR-126*
repress recruitment of mesenchymal stem cells and inflammatory
monocytes to inhibit breast cancer metastasis. Nat Cell Biol.
15:284–294. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Q, Hu H, Jiao D, Yan J, Xu W, Tang X,
Chen J and Wang J: miR-126-3p and miR-451a correlate with
clinicopathological features of lung adenocarcinoma: The underlying
molecular mechanisms. Oncol Rep. 36:909–917. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang R, Zhong T, Dang Y, Zhang X, Li P and
Chen G: Association between downexpression of miR-203 and poor
prognosis in non-small cell lung cancer patients. Clin Transl
Oncol. 18:360–368. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Verderio P, Bottelli S, Ciniselli CM,
Pierotti MA, Gariboldi M and Pizzamiglio S: NqA: An R-based
algorithm for the normalization and analysis of microRNA
quantitative real-time polymerase chain reaction data. Anal
Biochem. 461:7–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Benes V and Castoldi M: Expression
profiling of microRNA using real-time quantitative PCR, how to use
it and what is available. Methods. 50:244–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen G, Umelo IA, Lv S, Teugels E, Fostier
K, Kronenberger P, Dewaele A, Sadones J, Geers C and De Grève J:
MiR-146a inhibits cell growth, cell migration and induces apoptosis
in non-small cell lung cancer cells. PLoS One. 8:e603172013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ivo D, Urso P, Fernando D'Urso O, Damiano
Gianfreda C, Mezzolla V, Storelli C and Marsigliante S: miR-15b and
miR-21 as circulating biomarkers for diagnosis of glioma. Curr
Genomics. 16:304–311. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang XN, Guo RJ, Li S, Zheng ZM and Liang
HD: Binary logistic regression analysis of solid thyroid nodules
imaged by high-frequency ultrasonography, acoustic radiation force
impulse, and contrast-enhanced ultrasonography. Eur Rev Med
Pharmacol Sci. 18:3601–3610. 2014.PubMed/NCBI
|
|
26
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Seike M, Goto A, Okano T, Bowman ED,
Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, et
al: MiR-21 is an EGFR-regulated anti-apoptotic factor in lung
cancer in never-smokers. Proc Nal Acad Sci USA. 106:12085–12090.
2009. View Article : Google Scholar
|
|
28
|
Nymark P, Guled M, Borze I, Faisal A,
Lahti L, Salmenkivi K, Kettunen E, Anttila S and Knuutila S:
Integrative analysis of microRNA, mRNA and aCGH data reveals
asbestos- and histology-related changes in lung cancer. Genes
Chromosome Cancer. 50:585–597. 2011. View Article : Google Scholar
|
|
29
|
Ma L, Huang Y, Zhu W, Zhou S, Zhou J, Zeng
F, Liu X, Zhang Y and Yu J: An integrated analysis of miRNA and
mRNA expressions in non-small cell lung cancers. PLoS One.
6:e265022011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
van Jaarsveld MT, Wouters MD, Boersma AW,
Smid M, van Ijcken WF, Mathijssen RH, Hoeijmakers JH, Martens JW,
van Laere S, Wiemer EA and Pothof J: DNA damage responsive
microRNAs misexpressed in human cancer modulate therapy
sensitivity. Mol Oncol. 8:458–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bjaanaes MM, Halvorsen AR, Solberg S,
Jørgensen L, Dragani TA, Galvan A, Colombo F, Anderlini M,
Pastorino U, Kure E, et al: Unique microRNA-profiles in
EGFR-mutated lung adenocarcinomas. Int J Cancer. 135:1812–1821.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Arima C, Kajino T, Tamada Y, Imoto S,
Shimada Y, Nakatochi M, Suzuki M, Isomura H, Yatabe Y, Yamaguchi T,
et al: Lung adenocarcinoma subtypes definable by lung
development-related miRNA expression profiles in association with
clinicopathologic features. Carcinogenesis. 35:2224–2231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Robles AI, Arai E, Mathé EA, Okayama H,
Schetter AJ, Brown D, Petersen D, Bowman ED, Noro R, Welsh JA, et
al: An integrated prognostic classifier for stage I lung
adenocarcinoma based on mRNA, microRNA, and DNA methylation
biomarkers. J Thorac Oncol. 10:1037–1048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jin Y, Liu Y, Zhang J, Huang W, Jiang H,
Hou Y, Xu C, Zhai C, Gao X, Wang S, et al: The expression of
miR-375 is associated with carcinogenesis in three subtypes of lung
cancer. PLoS One. 10:e01441872015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yoshimoto T, Motoi N, Yamamoto N, Nagano
H, Ushijima M, Matsuura M, Okumura S, Yamaguchi T, Fukayama M and
Ishikawa Y: Pulmonary carcinoids and low-grade gastrointestinal
neuroendocrine tumors show common MicroRNA expression profiles,
different from adenocarcinomas and small cell carcinomas.
Neuroendocrinology. 106:47–57. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiong Y, Kotian S, Zeiger MA, Zhang L and
Kebebew E: MiR-126-3p inhibits thyroid cancer cell growth and
metastasis, and is associated with aggressive thyroid cancer. PLoS
One. 10:e01304962015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie
H, Zhou L, Wu J and Zheng S: MiR-126-3p suppresses tumor metastasis
and angiogenesis of hepatocellular carcinoma by targeting LRP6 and
PIK3R2. J Transl Med. 12:2592014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu W, Chen H, Wong N, Haynes W, Baker CM
and Wang X: Pseudohypoxia induced by miR-126 deactivation promotes
migration and therapeutic resistance in renal cell carcinoma.
Cancer Lett. 394:65–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li J, Ping JL, Ma B, Chen YR and Li LQ:
Deregulation of miR-126-3p in basal-like breast cancers stroma and
its clinical significance. Pathol Res Pract. 213:922–928. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fiala O, Pitule P, Hosek P, Liska V,
Sorejs O, Bruha J, Vycital O, Buchler T, Poprach A, Topolcan O and
Finek J: The association of miR-126-3p, miR-126-5p and miR-664-3p
expression profiles with outcomes of patients with metastatic
colorectal cancer treated with bevacizumab. Tumour Biol.
39:10104283177092832017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kong R, Ma Y, Feng J, Li S, Zhang W, Jiang
J, Zhang J, Qiao Z, Yang X and Zhou B: The crucial role of miR-126
on suppressing progression of esophageal cancer by targeting
VEGF-A. Cell Mol Biol Lett. 21:32016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sasahira T, Kurihara M, Bhawal UK, Ueda N,
Shimomoto T, Yamamoto K, Kirita T and Kuniyasu H: Downregulation of
miR-126 induces angiogenesis and lymphangiogenesis by activation of
VEGF-A in oral cancer. Br J Cancer. 107:700–706. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Paszek S, Gabło N, Barnaś E, Szybka M,
Morawiec J, Kołacińska A and Zawlik I: Dysregulation of microRNAs
in triple-negative breast cancer. Ginekol Pol. 88:530–536. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jinushi T, Shibayama Y, Kinoshita I,
Oizumi S, Jinushi M, Aota T, Takahashi T, Horita S, Dosaka-Akita H
and Iseki K: Low expression levels of microRNA-124-5p correlated
with poor prognosis in colorectal cancer via targeting of SMC4.
Cancer Med. 3:1544–1552. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Peng Z, Pan L, Niu Z, Li W, Dang X, Wan L,
Zhang R and Yang S: Identification of microRNAs as potential
biomarkers for lung adenocarcinoma using integrating genomics
analysis. Oncotarget. 8:64143–64156. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jusufović E, Rijavec M, Keser D, Korošec
P, Sodja E, Iljazović E, Radojević Z and Košnik M: let-7b and
miR-126 are down-regulated in tumor tissue and correlate with
microvessel density and survival outcomes in non-small-cell lung
cancer. PLoS One. 7:e455772012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu B, Peng XC, Zheng XL, Wang J and Qin
YW: MiR-126 restoration down-regulate VEGF and inhibit the growth
of lung cancer cell lines in vitro and in vivo. Lung Cancer.
66:169–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Song L, Li D, Gu Y, Wen ZM, Jie J, Zhao D
and Peng LP: MicroRNA-126 targeting PIK3R2 inhibits NSCLC A549 cell
proliferation, migration, and invasion by regulation of
PTEN/PI3K/AKT pathway. Clin Lung Cancer. 17:e65–e75. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Huang CJ, Nguyen PN, Choo KB, Sugii S, Wee
K, Cheong SK and Kamarul T: Frequent co-expression of miRNA-5p and
−3p species and cross-targeting in induced pluripotent stem cells.
Int J Med Sci. 11:824–833. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gong F, Ren P, Zhang Y, Jiang J and Zhang
H: MicroRNAs-491-5p suppresses cell proliferation and invasion by
inhibiting IGF2BP1 in non-small cell lung cancer. Am J Transl Res.
8:485–495. 2016.PubMed/NCBI
|
|
51
|
Du GJ, Li JH, Liu WJ, Liu YH, Zhao B, Li
HR, Hou XD, Li H, Qi XX and Duan YJ: The combination of TRPM8 and
TRPA1 expression causes an invasive phenotype in lung cancer.
Tumour Biol. 35:1251–1261. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lin H, Qiu S, Xie L, Liu C and Sun S:
Nimbolide suppresses non-small cell lung cancer cell invasion and
migration via manipulation of DUSP4 expression and ERK1/2
signaling. Biomed Pharmacother. 92:340–346. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Walter RF, Mairinger FD, Werner R, Ting S,
Vollbrecht C, Theegarten D, Christoph DC, Zarogoulidis K, Schmid
KW, Zarogoulidis P and Wohlschlaeger J: SOX4, SOX11 and PAX6 mRNA
expression was identified as a (prognostic) marker for the
aggressiveness of neuroendocrine tumors of the lung by using
next-generation expression analysis (NanoString). Future Oncol.
11:1027–1036. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Du H, Chen Y, Hou X, Huang Y, Wei X, Yu X,
Feng S, Wu Y, Zhan M, Shi X, et al: PLOD2 regulated by
transcription factor FOXA1 promotes metastasis in NSCLC. Cell Death
Dis. 8:e31432017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liu WL, Chang JM, Chong IW, Hung YL, Chen
YH, Huang WT, Kuo HF, Hsieh CC and Liu PL: Curcumin inhibits
LIN-28A through the activation of miRNA-98 in the lung cancer cell
line A549. Molecules. 22:E9292017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang WC, Shyh-Chang N, Yang H, Rai A,
Umashankar S, Ma S, Soh BS, Sun LL, Tai BC, Nga ME, et al: Glycine
decarboxylase activity drives non-small cell lung cancer
tumor-initiating cells and tumorigenesis. Cell. 148:259–272. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Cohen AS, Khalil FK, Welsh EA, Schabath
MB, Enkemann SA, Davis A, Zhou JM, Boulware DC, Kim J, Haura EB and
Morse DL: Cell-surface marker discovery for lung cancer.
Oncotarget. 8:113373–113402. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Choo KB, Soon YL, Nguyen PN, Hiew MS and
Huang CJ: MicroRNA-5p and −3p co-expression and cross-targeting in
colon cancer cells. J Biomed Sci. 21:952014. View Article : Google Scholar : PubMed/NCBI
|
